MAPT and Alzheimer disease: AD is thought to have several pathophysiological and biochemical changes that cause progression of disease such as hyperphosphorylation of tau proteins, amyloid-beta cleavage, presence of specific genetic phenotypes, and other idiopathic causes (Yarns et al., 2022).